Credit Agricole’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-32,000
Closed -$264K 1499
2015
Q1
$264K Hold
32,000
﹤0.01% 1306
2014
Q4
$219K Hold
32,000
﹤0.01% 1392
2014
Q3
$173K Buy
32,000
+14,011
+78% +$81.8K ﹤0.01% 1384
2014
Q2
$114K Sell
17,989
-8,461
-32% -$58.2K ﹤0.01% 1452
2014
Q1
$213K Buy
26,450
+15,300
+137% +$119K ﹤0.01% 1264
2013
Q4
$76K Sell
11,150
-33,100
-75% -$179K ﹤0.01% 1390
2013
Q3
$814K Buy
+44,250
New +$859K ﹤0.01% 1074

Other funds holding ARIA

Credit Agricole's ARIA Position: Q2 2015 in Review

Credit Agricole sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2015, closing a stake of 32,000 shares — an estimated $264K sold.

Credit Agricole first reported a position in ARIA in Q3 2013 and held it in 7 quarters. The position peaked at $814K in Q3 2013. 177 funds tracked by Wall St. Rank hold ARIA as of Q2 2015.

  • Credit Agricole reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Credit Agricole sold 32,000 Ariad Pharmaceuticals Inc shares in Q2 2015, an estimated $264K.
  • Credit Agricole first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 7 quarters.
  • Credit Agricole's Ariad Pharmaceuticals Inc position peaked at $814K in Q3 2013.
  • 177 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2015.

Based on Credit Agricole's 13F filing for Q2 2015, filed 12 Aug 2015.